<DOC>
	<DOCNO>NCT01635452</DOCNO>
	<brief_summary>This multi-center , prospective , non-interventional study patient diagnose moderate severe symptom uterine fibroid initiate pre-operative treatment ESMYA . The objective study characterize describe treatment ESMYA evaluate safety , effectiveness , HRQL outcomes population</brief_summary>
	<brief_title>A Prospective Multicenter Non-interventional Study Women Treated With ESMYA ( Ulipristal Acetate ) Pre-operative Treatment Moderate Severe Symptoms Uterine Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Premenopausal adult woman diagnosis moderate severe symptom uterine fibroid initiate treatment ESMYA . Patient pregnant plan become pregnant next 3 month , Patient breastfeeding , Patient genital bleed unknown etiology due uterine fibroid , Patient diagnose uterine , cervical , ovarian breast cancer , Patient use investigational drug/therapy discontinue use investigational drug/therapy within 30 day prior study enrollment , Patient hypersensitivity active substance ESMYA one excipients</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>